{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:44:57Z","timestamp":1793108697575,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.immuni.2026.05.014","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:52:14Z","timestamp":1781535134000},"page":"1982-1998.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neutrophil regulation of immunotherapy for cancer is controlled by type II interferon"],"prefix":"10.1016","volume":"59","author":[{"given":"Shengduo","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qirong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey V.","family":"Ravetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Soehnlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5582-614X","authenticated-orcid":false,"given":"Mikael C.I.","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2026.05.014_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-Related Adverse Events Associated with Immune Checkpoint Blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.immuni.2026.05.014_bib3","article-title":"Immune-related adverse events for anti-PD-1 and anti-PD-L1 drugs: systematic review and meta-analysis","volume":"360","author":"Baxi","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.immuni.2026.05.014_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2026.05.014_bib6","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1038\/s41590-024-02006-5","article-title":"The diverse roles of neutrophils from protection to pathogenesis","volume":"25","author":"Herro","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib7","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: A consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.immuni.2026.05.014_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccell.2023.12.005","article-title":"Interferon-stimulated neutrophils as a predictor of immunotherapy response","volume":"42","author":"Benguigui","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.immuni.2026.05.014_bib10","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","article-title":"A neutrophil response linked to tumor control in immunotherapy","volume":"186","author":"Gungabeesoon","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.014_bib12","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.immuni.2025.07.011","article-title":"From complexity to consensus: A roadmap for neutrophil classification","volume":"58","author":"Ng","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.014_bib13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ccell.2024.04.011","article-title":"Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy","volume":"42","author":"van Elsas","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.immuni.2024.12.009","article-title":"Adaptations of neutrophils in cancer","volume":"58","author":"Ng","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.014_bib15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41586-025-09807-0","article-title":"Architecture of the neutrophil compartment","volume":"649","author":"Cerezo-Wallis","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.014_bib16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/s41590-020-0736-z","article-title":"Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection","volume":"21","author":"Xie","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf6493","article-title":"Deterministic reprogramming of neutrophils within tumors","volume":"383","author":"Ng","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.immuni.2026.05.014_bib18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41586-019-1167-6","article-title":"Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death","volume":"569","author":"Silvestre-Roig","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2026.05.014_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.immuni.2018.02.002","article-title":"Developmental Analysis of Bone Marrow Neutrophils Reveals Populations Specialized in Expansion, Trafficking, and Effector Functions","volume":"48","author":"Evrard","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.014_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.immuni.2019.01.002","article-title":"A Neutrophil Timer Coordinates Immune Defense and Vascular Protection","volume":"50","author":"Adrover","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.014_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072249","article-title":"IFN-gamma-stimulated neutrophils suppress lymphocyte proliferation through expression of PD-L1","volume":"8","author":"de Kleijn","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.immuni.2026.05.014_bib22","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1182\/blood-2016-05-718999","article-title":"Aged neutrophils contribute to the first line of defense in the acute inflammatory response","volume":"128","author":"Uhl","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2026.05.014_bib23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.cell.2018.09.030","article-title":"High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy","volume":"175","author":"Gubin","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib24","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.7150\/thno.26888","article-title":"Arg1 expression defines immunosuppressive subsets of tumor-associated macrophages","volume":"8","author":"Arlauckas","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.immuni.2026.05.014_bib25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-gamma and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2026.05.014_bib26","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.05.014_bib27","doi-asserted-by":"crossref","first-page":"32005","DOI":"10.1073\/pnas.2015343117","article-title":"Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells","volume":"117","author":"Eisinger","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2026.05.014_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2026.05.014_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cell.2004.10.010","article-title":"JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells","volume":"119","author":"Passegu\u00e9","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib30","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4049\/jimmunol.1701231","article-title":"Dendritic Cell PD-L1 Limits Autoimmunity and Follicular T Cell Differentiation and Function","volume":"200","author":"Sage","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi7083","article-title":"Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy","volume":"6","author":"Siwicki","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ccell.2023.01.002","article-title":"Neutrophil-activating therapy for the treatment of cancer","volume":"41","author":"Linde","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","article-title":"Tumor entrained neutrophils inhibit seeding in the premetastatic lung","volume":"20","author":"Granot","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib34","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.4049\/jimmunol.1300910","article-title":"Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-gamma receptor subunit 1 (IFNGR1)","volume":"191","author":"Lee","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib35","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41590-022-01311-1","article-title":"Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress","volume":"23","author":"Montaldo","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.immuni.2026.05.014_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd9436","article-title":"PD-L1(+) neutrophils contribute to injury-induced infection susceptibility","volume":"7","author":"Thanabalasuriar","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.immuni.2026.05.014_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-92417-7","article-title":"Immune suppressive activities of low-density neutrophils in sepsis and potential use as a novel biomarker of sepsis-induced immune suppression","volume":"15","author":"Charoensappakit","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.immuni.2026.05.014_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/SHK.0000000000002602","article-title":"ASSOCIATION BETWEEN LONGITUDINAL CHANGES IN SERUM SOLUBLE PD-L1 LEVELS AND NEUTROPHIL PD-L1 mRNA EXPRESSION WITH OUTCOME IN A HETEROGENEOUS GENERAL ICU POPULATION","volume":"64","author":"Kokkoris","year":"2025","journal-title":"Shock"},{"key":"10.1016\/j.immuni.2026.05.014_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-025-06351-3","article-title":"Single-cell transcriptomic analysis reveals dynamic changes in the liver microenvironment during colorectal cancer metastatic progression","volume":"23","author":"Jiang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.immuni.2026.05.014_bib41","article-title":"Quantitative analysis of immune cells within the tumor microenvironment of glioblastoma and their relevance for prognosis","volume":"142","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.immuni.2026.05.014_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-024-01244-9","article-title":"Neutrophils in cancer: from biology to therapy","volume":"22","author":"Koenderman","year":"2025","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.immuni.2026.05.014_bib43","article-title":"The multiple roles of interferon regulatory factor family in health and disease","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.immuni.2026.05.014_bib44","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","article-title":"Interferon-gamma induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation","volume":"81","author":"Yu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","article-title":"Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression","volume":"19","author":"Garcia-Diaz","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.immuni.2026.05.014_bib46","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/bjc.2015.101","article-title":"IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer","volume":"112","author":"Abiko","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.immuni.2026.05.014_bib47","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2026.05.014_bib48","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb.)"},{"key":"10.1016\/j.immuni.2026.05.014_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.immuni.2026.05.014_bib50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761326002256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:30:41Z","timestamp":1793107841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761326002256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1074761326002256"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.014","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil regulation of immunotherapy for cancer is controlled by type II interferon","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2026.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}